Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Aug 31
Love0

Cardamonin Inhibits Keloid Fibroblast Activation and Extracellular Matrix Production Through Suppression of TGF-β1/Smad Signaling

By Chuck Lin No Comments
INTRODUCTIONKeloid is a type of benign fibroproliferative skin disorder that results from excessive wound healing following skin trauma or inflammation and often extends beyond the original wound site, causing pain,…
Read More
Aug 31
Love0

Safety and Tolerability of Facial Skincare in Children and Adolescents: Clinical Testing and Multigenerational Insights

By Chuck Lin No Comments
INTRODUCTIONGrowing consumer engagement with skincare across all age groups, including a documented trend toward early-onset use in children and adolescents, has spurred robust discussion in the dermatologic community. Skincare trends…
Read More
Aug 31
Love0

Clinical Evidence of Skin Improvements With a Biologically Active Multimodal Topical Skin Treatment

By Chuck Lin No Comments
INTRODUCTIONAge-related changes in the biomechanical properties of skin are important considerations for aesthetic applications including plastic surgery and dermatology, and the increasing need for effective and tolerable treatments for aging…
Read More
Aug 31
Love0

Topical Carboxytherapy as an Adjunct to Skin Recovery Post-CO2 Laser Fractional Resurfacing

By Chuck Lin No Comments
INTRODUCTIONFractional carbon dioxide (CO₂) laser skin resurfacing is widely recognized as the gold standard for skin rejuvenation. Its effectiveness is based on the principle of selective photothermolysis, wherein the CO₂…
Read More
Aug 31
Love0

INDIVIDUAL ARTICLE: Real-World Cases Using Phyto Polydeoxyribonucleotide (PDRN) Serum

By Chuck Lin No Comments
INTRODUCTIONInflammation and photodamage are largely considered the leading contributors to premature skin aging as they lead to decreased collagen content in the skin.1 Collagen, the most abundant protein in the…
Read More
Aug 31
Love0

FULL SUPPLEMENT: Real-World Split-Face Case Series of a Phyto Polydeoxyribonucleotide (PDRN) Serum in Integrative Skincare

By Chuck Lin No Comments
In this issue:Real-World Cases Using Phyto Polydeoxyribonucleotide (PDRN) Serum Integrative skincare refers to a clinician-directed regimen that combines aesthetic procedures with appropriate post-procedure skincare. The novel phyto polydeoxyribonucleotides (PDRN) formulation…
Read More
Aug 31
Love0

INDIVIDUAL ARTICLE: Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis and prurigo nodularis represent the two most burdensome pruritic inflammatory skin diseases encountered in clinical dermatology. While distinct in morphology, chronicity, and epidemiology, both conditions are united by…
Read More
Aug 31
Love0

FULL SUPPLEMENT: The Role of IL 31 Inhibition in Atopic Dermatitis

By Chuck Lin No Comments
In this issue:Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab This manuscript provides an integrated review of IL-31 pathophysiology in AD and PN…
Read More
Aug 29
Love0

Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part II– Scarring Disorders

By Chuck Lin No Comments
INTRODUCTIONEyebrows play an essential role in facial symmetry, communication, and aesthetic identity.1,2 Scarring, or cicatricial, eyebrow alopecia involves a diverse group of inflammatory, autoimmune, infectious, and traumatic processes that destroy…
Read More
Aug 29
Love0

Risk Factors Associated With Hyaluronic Acid Filler-Related Delayed Complications: A Literature Review and Expert Consensus

By Chuck Lin No Comments
INTRODUCTIONHyaluronic acid (HA) filler injection is the second most commonly performed nonsurgical aesthetic procedure globally. HA filler use has risen sharply, driven by advantages over earlier collagen-based fillers, such as…
Read More
Aug 29
Love0

JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort Study

By Chuck Lin No Comments
INTRODUCTIONKeloids and hypertrophic scars are benign fibroproliferative skin disorders characterized by excessive and disorganized collagen deposition extending beyond the original wound margins, typically arising after cutaneous injury, surgery, inflammation, or…
Read More
Aug 29
Love0

Treatment Adherence in Patients With Acne Vulgaris: A Narrative Review

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris is a common, chronic dermatologic condition with an estimated global prevalence of 9.4% across age groups.1,2 The condition presents as open or closed comedones, papules, pustules, or nodules…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Treatment Adherence in Patients With Acne Vulgaris: A Narrative Review September 18, 2026
  • JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort Study September 17, 2026
  • Author Spotlight: Jessica L. Feig MD PhD September 15, 2026
  • Prescription-Strength Acne Science, Now OTC: The Clinical Confidence Behind Differin® Epiduo® September 14, 2026
  • JDD September 2026 Highlights and Editor Picks September 14, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram